SMS Pharma promoters boost stake via warrant conversion

Vamsi Krishna Potluri, a promoter of SMS Pharmaceuticals Limited, along with persons acting in concert (PACs), has disclosed the acquisition of shares through the conversion of warrants into equity shares, effective September 10, 2025. This action falls under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Specifically, 50m warrants were converted into 50m equity shares. Of these, 25m equity shares were allotted to Vamsi Krishna Potluri and another 25m equity shares to Trilok Potluri, as a person acting in concert. This conversion has increased the total equity share capital of SMS Pharmaceuticals from 8,86,52,030 equity shares of Re1 to 9,36,52,030 equity shares of Re1.

Following this acquisition, the total holding of Vamsi Krishna Potluri and PACs, including shares carrying voting rights and encumbered shares, now stands at 6,37,45,010 shares, representing 71.90% of the total share/voting capital. The diluted share/voting capital of the company after this conversion is 9,36,52,030 equity shares of Re1.